These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 26130255)

  • 1. Bortezomib Inhibits Osteoclastogenesis and Porphyromonas gingivalis Lipopolysaccharide-induced Alveolar Bone Resorption.
    Kim YG; Kang JH; Kim HJ; Kim HJ; Kim HH; Kim JY; Lee Y
    J Dent Res; 2015 Sep; 94(9):1243-50. PubMed ID: 26130255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel Bruton's tyrosine kinase inhibitor, acalabrutinib, suppresses osteoclast differentiation and Porphyromonas gingivalis lipopolysaccharide-induced alveolar bone resorption.
    Pokhrel NK; Kim YG; Kim HJ; Kim HJ; Lee JH; Choi SY; Kwon TG; Lee HJ; Kim JY; Lee Y
    J Periodontol; 2019 May; 90(5):546-554. PubMed ID: 30387495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bortezomib inhibits human osteoclastogenesis.
    von Metzler I; Krebbel H; Hecht M; Manz RA; Fleissner C; Mieth M; Kaiser M; Jakob C; Sterz J; Kleeberg L; Heider U; Sezer O
    Leukemia; 2007 Sep; 21(9):2025-34. PubMed ID: 17581612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluvastatin Inhibits Osteoclast Differentiation and Porphyromonas gingivalis Lipopolysaccharide-Induced Alveolar Bone Erosion in Mice.
    Pokhrel NK; Kim YG; Kim JY; Kim HH; Lee Y
    J Periodontol; 2017 Apr; 88(4):390-398. PubMed ID: 27858552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Micromolar sodium fluoride mediates anti-osteoclastogenesis in Porphyromonas gingivalis-induced alveolar bone loss.
    Bhawal UK; Lee HJ; Arikawa K; Shimosaka M; Suzuki M; Toyama T; Sato T; Kawamata R; Taguchi C; Hamada N; Nasu I; Arakawa H; Shibutani K
    Int J Oral Sci; 2015 Dec; 7(4):242-9. PubMed ID: 26674426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteasome inhibition aggravates tumor necrosis factor-mediated bone resorption in a mouse model of inflammatory arthritis.
    Polzer K; Neubert K; Meister S; Frey B; Baum W; Distler JH; Gückel E; Schett G; Voll RE; Zwerina J
    Arthritis Rheum; 2011 Mar; 63(3):670-80. PubMed ID: 21360496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Caffeic acid 3,4-dihydroxy-phenethyl ester suppresses receptor activator of NF-κB ligand–induced osteoclastogenesis and prevents ovariectomy-induced bone loss through inhibition of mitogen-activated protein kinase/activator protein 1 and Ca2+–nuclear factor of activated T-cells cytoplasmic 1 signaling pathways.
    Wu X; Li Z; Yang Z; Zheng C; Jing J; Chen Y; Ye X; Lian X; Qiu W; Yang F; Tang J; Xiao J; Liu M; Luo J
    J Bone Miner Res; 2012 Jun; 27(6):1298-1308. PubMed ID: 22337253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platycarya strobilacea leaf extract inhibits tumor necrosis factor-α production and bone loss induced by Porphyromonas gingivalis-derived lipopolysaccharide.
    Lee JH; Kim H; Shim JH; Park J; Lee SK; Park KK; Chung WY
    Arch Oral Biol; 2018 Dec; 96():46-51. PubMed ID: 30172945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bortezomib inhibits maturation and function of osteoclasts from PBMCs of patients with multiple myeloma by downregulating TRAF6.
    Hongming H; Jian H
    Leuk Res; 2009 Jan; 33(1):115-22. PubMed ID: 18778854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bee venom attenuates Porphyromonas gingivalis and RANKL-induced bone resorption with osteoclastogenic differentiation.
    Gu H; An HJ; Kim JY; Kim WH; Gwon MG; Kim HJ; Han SM; Park I; Park SC; Leem J; Park KK
    Food Chem Toxicol; 2019 Jul; 129():344-353. PubMed ID: 31055000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lenalidomide inhibits osteoclastogenesis, survival factors and bone-remodeling markers in multiple myeloma.
    Breitkreutz I; Raab MS; Vallet S; Hideshima T; Raje N; Mitsiades C; Chauhan D; Okawa Y; Munshi NC; Richardson PG; Anderson KC
    Leukemia; 2008 Oct; 22(10):1925-32. PubMed ID: 18596740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bortezomib prevents ovariectomy-induced osteoporosis in mice by inhibiting osteoclast differentiation.
    Kim SH; Kim MO; Kim HJ; Neupane S; Kim HJ; Lee JH; Kim HH; Kim JY; Lee Y
    J Bone Miner Metab; 2018 Sep; 36(5):537-546. PubMed ID: 29027021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of RANKL-induced osteoclastogenesis by (-)-DHMEQ, a novel NF-kappaB inhibitor, through downregulation of NFATc1.
    Takatsuna H; Asagiri M; Kubota T; Oka K; Osada T; Sugiyama C; Saito H; Aoki K; Ohya K; Takayanagi H; Umezawa K
    J Bone Miner Res; 2005 Apr; 20(4):653-62. PubMed ID: 15765185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant thrombomodulin lectin-like domain attenuates Porphyromonas gingivalis lipopolysaccharide-induced osteoclastogenesis and periodontal bone resorption.
    Chang LY; Lai CH; Kuo CH; Chang BI; Wu HL; Cheng TL
    J Periodontol; 2021 Nov; 92(11):1622-1634. PubMed ID: 33438207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Collinin reduces Porphyromonas gingivalis growth and collagenase activity and inhibits the lipopolysaccharide-induced macrophage inflammatory response and osteoclast differentiation and function.
    Santos J; Marquis A; Epifano F; Genovese S; Curini M; Grenier D
    J Periodontol; 2013 May; 84(5):704-11. PubMed ID: 22897650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pulse treatment with the proteasome inhibitor bortezomib inhibits osteoclast resorptive activity in clinically relevant conditions.
    Boissy P; Andersen TL; Lund T; Kupisiewicz K; Plesner T; Delaissé JM
    Leuk Res; 2008 Nov; 32(11):1661-8. PubMed ID: 18394701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of receptor activator of nuclear factor-κB ligand- or lipopolysaccharide-induced osteoclast formation by conophylline through downregulation of CREB.
    Koide N; Kondo Y; Odkhuu E; Ulziisaikhan J; Ukaji T; Yokochi T; Umezawa K
    Immunol Lett; 2014 Sep; 161(1):31-7. PubMed ID: 24792671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Porphyromonas gingivalis Stimulates Bone Resorption by Enhancing RANKL (Receptor Activator of NF-κB Ligand) through Activation of Toll-like Receptor 2 in Osteoblasts.
    Kassem A; Henning P; Lundberg P; Souza PP; Lindholm C; Lerner UH
    J Biol Chem; 2015 Aug; 290(33):20147-58. PubMed ID: 26085099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipopolysaccharide from Prevotella nigrescens stimulates osteoclastogenesis in cocultures of bone marrow mononuclear cells and primary osteoblasts.
    Chung YH; Chang EJ; Kim SJ; Kim HH; Kim HM; Lee SB; Ko JS
    J Periodontal Res; 2006 Aug; 41(4):288-96. PubMed ID: 16827722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trapidil, a platelet-derived growth factor antagonist, inhibits osteoclastogenesis by down-regulating NFATc1 and suppresses bone loss in mice.
    Kim SD; Kim HN; Lee JH; Jin WJ; Hwang SJ; Kim HH; Ha H; Lee ZH
    Biochem Pharmacol; 2013 Sep; 86(6):782-90. PubMed ID: 23928189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.